RU2018120744A3 - - Google Patents

Download PDF

Info

Publication number
RU2018120744A3
RU2018120744A3 RU2018120744A RU2018120744A RU2018120744A3 RU 2018120744 A3 RU2018120744 A3 RU 2018120744A3 RU 2018120744 A RU2018120744 A RU 2018120744A RU 2018120744 A RU2018120744 A RU 2018120744A RU 2018120744 A3 RU2018120744 A3 RU 2018120744A3
Authority
RU
Russia
Application number
RU2018120744A
Other languages
Russian (ru)
Other versions
RU2018120744A (ru
RU2809788C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018120744A publication Critical patent/RU2018120744A/ru
Publication of RU2018120744A3 publication Critical patent/RU2018120744A3/ru
Application granted granted Critical
Publication of RU2809788C2 publication Critical patent/RU2809788C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35—Valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567—Framework region [FR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
RU2018120744A 2014-05-16 2015-05-13 Улучшенные вариабельные домены иммуноглобулина RU2809788C2 (ru)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201461994552P 2014-05-16 2014-05-16
US61/994,552 2014-05-16
US201462014015P 2014-06-18 2014-06-18
US201461014015P 2014-06-18 2014-06-18
US62/014,015 2014-06-18
US201462040167P 2014-08-21 2014-08-21
US62/040,167 2014-08-21
US201462047560P 2014-09-08 2014-09-08
US62/047,560 2014-09-08
US201562133600P 2015-03-16 2015-03-16
US62/133,600 2015-03-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2016149463A Division RU2746738C2 (ru) 2014-05-16 2015-05-13 Улучшенные вариабельные домены иммуноглобулина

Publications (3)

Publication Number Publication Date
RU2018120744A RU2018120744A (ru) 2018-11-15
RU2018120744A3 true RU2018120744A3 (enExample) 2022-01-28
RU2809788C2 RU2809788C2 (ru) 2023-12-18

Family

ID=

Also Published As

Publication number Publication date
US12180268B2 (en) 2024-12-31
KR20170002645A (ko) 2017-01-06
IL248636B (en) 2022-12-01
ZA201607587B (en) 2022-05-25
JP2024069377A (ja) 2024-05-21
AU2018204226A1 (en) 2018-07-05
US20220251183A1 (en) 2022-08-11
US20220332806A1 (en) 2022-10-20
IL311293A (en) 2024-05-01
CN109053885A (zh) 2018-12-21
IL281755B1 (en) 2023-01-01
ZA202004757B (en) 2022-08-31
WO2015173325A3 (en) 2016-02-18
RU2021107470A (ru) 2021-05-17
AU2015261536A1 (en) 2016-11-17
DK3143042T3 (da) 2020-08-31
RS63085B1 (sr) 2022-04-29
ZA202100742B (en) 2022-09-28
AU2020202570B2 (en) 2022-12-08
HRP20200966T1 (hr) 2020-10-16
IL248636B2 (en) 2023-04-01
US11312765B2 (en) 2022-04-26
IL299282A (en) 2023-02-01
AU2020202855B2 (en) 2022-12-08
RU2018120744A (ru) 2018-11-15
JP7471987B2 (ja) 2024-04-22
AU2020202855A1 (en) 2020-05-21
US20210261653A1 (en) 2021-08-26
IL295534B2 (en) 2025-03-01
DK3248986T3 (da) 2022-04-04
HUE050007T2 (hu) 2020-11-30
PL3143042T3 (pl) 2020-11-16
US11312764B2 (en) 2022-04-26
IL248636A0 (en) 2017-01-31
US11485777B2 (en) 2022-11-01
SG10201805288QA (en) 2018-07-30
AU2022279374B2 (en) 2026-01-15
EP3143042A2 (en) 2017-03-22
PH12016502282A1 (en) 2017-02-13
MX383560B (es) 2025-03-14
MX2023010731A (es) 2023-09-20
AU2026203709A1 (en) 2026-06-04
ZA202004759B (en) 2022-08-31
ES2912069T3 (es) 2022-05-24
JP2021130681A (ja) 2021-09-09
CN113717280A (zh) 2021-11-30
MX2018007581A (es) 2020-11-12
LT3248986T (lt) 2022-03-25
US20210269514A1 (en) 2021-09-02
JP7325928B2 (ja) 2023-08-15
ZA202004758B (en) 2022-08-31
AU2022279373B2 (en) 2026-06-11
JP7881627B2 (ja) 2026-06-29
IL311293B2 (en) 2025-07-01
SG10201810124PA (en) 2018-12-28
EP3702369A1 (en) 2020-09-02
US20220135657A9 (en) 2022-05-05
PT3248986T (pt) 2022-04-05
PL3248986T3 (pl) 2022-05-16
US11319364B2 (en) 2022-05-03
EP3248986B1 (en) 2022-01-26
US20200231662A1 (en) 2020-07-23
AU2022279374A1 (en) 2023-01-19
RU2746738C2 (ru) 2021-04-20
CA3175002A1 (en) 2015-11-19
CA2948076A1 (en) 2015-11-19
US11220539B2 (en) 2022-01-11
RU2016149463A3 (enExample) 2018-07-04
EP4707303A2 (en) 2026-03-11
EP4707303A9 (en) 2026-04-29
SI3248986T1 (sl) 2022-04-29
EP3693386A1 (en) 2020-08-12
US20210269515A1 (en) 2021-09-02
JP2017518072A (ja) 2017-07-06
US20220119512A1 (en) 2022-04-21
AU2015261536B2 (en) 2020-05-07
AU2022279373A1 (en) 2023-01-19
JP2021006563A (ja) 2021-01-21
MX2021007020A (es) 2021-08-05
CN106661100A (zh) 2017-05-10
US11485778B2 (en) 2022-11-01
PH12016502282B1 (en) 2024-05-22
IL281755B2 (en) 2023-05-01
AU2020202570A1 (en) 2020-05-07
IL299282B2 (en) 2024-09-01
IL281755A (en) 2021-05-31
JP2024041939A (ja) 2024-03-27
RU2016149463A (ru) 2018-06-19
JP7454525B2 (ja) 2024-03-22
KR102827683B1 (ko) 2025-06-30
HUE058008T2 (hu) 2022-06-28
JP7098439B2 (ja) 2022-07-11
EP3248986A3 (en) 2017-12-20
IL299282B1 (en) 2024-05-01
US20170121399A1 (en) 2017-05-04
LT3143042T (lt) 2020-07-27
HRP20220400T1 (hr) 2022-05-27
RS60717B1 (sr) 2020-09-30
IL259972A (en) 2018-07-31
JP2026071402A (ja) 2026-04-28
KR20230053002A (ko) 2023-04-20
IL311293B1 (en) 2025-03-01
KR20230054503A (ko) 2023-04-24
US11708404B2 (en) 2023-07-25
BR122018009619B1 (pt) 2024-01-02
EP3143042B1 (en) 2020-06-10
JP2018162297A (ja) 2018-10-18
SI3143042T1 (sl) 2020-08-31
NZ726448A (en) 2023-02-24
IL259972B (en) 2021-04-29
MX2016014926A (es) 2017-05-09
US20210087261A1 (en) 2021-03-25
EP3248986A2 (en) 2017-11-29
KR20180091115A (ko) 2018-08-14
ES2815572T3 (es) 2021-03-30
BR112016026773A2 (pt) 2017-12-12
WO2015173325A8 (en) 2016-12-29
KR102769509B1 (ko) 2025-02-17
PT3143042T (pt) 2020-09-01
US20220332807A1 (en) 2022-10-20
IL295534B1 (en) 2024-11-01
IL295534A (en) 2022-10-01
WO2015173325A2 (en) 2015-11-19
KR20230145503A (ko) 2023-10-17
SG11201609162SA (en) 2016-12-29

Similar Documents

Publication Publication Date Title
BR112016017664A2 (enExample)
BR112016017979A2 (enExample)
BR112016015519A2 (enExample)
BR112016015890A2 (enExample)
BR112016016490A2 (enExample)
BR112016016546A2 (enExample)
BR112016018264A2 (enExample)
BR112016017103A2 (enExample)
BR112016016612A2 (enExample)
BR112016016421A2 (enExample)
BR112016016106A2 (enExample)
BR112016012568A2 (enExample)
BR112016016558A2 (enExample)
BR112016017960A2 (enExample)
BR112016015915A2 (enExample)
BR112016018252A2 (enExample)
BR112016017216A2 (enExample)
BR112016016468A2 (enExample)
BR112016017356A2 (enExample)
BR112016016459A2 (enExample)
BR112016003522A2 (enExample)
BR112016014482A2 (enExample)
BR112016030569A2 (enExample)
BR112016018021A2 (enExample)
BR112016015054A2 (enExample)